1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Chazin, W.J.
Ohi, M.D.
Vander Kooi, C.W.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Nat.Struct.Biol.
NSBIEW
2024
1072-8368
10
250
255
10.1038/nsb906
12627222
Structural insights into the U-box, a domain associated with multi-ubiquitination
2003
10.2210/pdb1n87/pdb
pdb_00001n87
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1
SINGLE WAVELENGTH
M
1
1.0
6246.232
Pre-mRNA splicing factor PRP19
1
man
polymer
no
no
MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVPS
MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVPS
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
baker's yeast
Saccharomyces
Escherichia
Escherichia coli
sample
Prp19
4932
Saccharomyces cerevisiae
511693
Escherichia coli BL21
BL21
Plasmid
pET15b
database_2
pdbx_nmr_software
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2003-04-15
1
1
2008-04-28
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
RCSB
Y
RCSB
2002-11-19
REL
REL
structures with the least restraint violations,structures with the lowest energy
50
20
2D NOESY
2D TOCSY
3D_15N-separated_NOESY
3D_13C-separated_NOESY
3D_13C-separated_NOESY
0.28
7.0
ambient
303
K
Torsion angle dynamics, Molecular dynamics
1
closest to the average
1mM Prp19(1-73); UL 20mM phosphate buffer pH 7.0; 20mM NaCl
95% H2O/5% D2O
1mM Prp19(1-73); U-15N 20mM phosphate buffer pH 7.0; 20mM NaCl
95% H2O/5% D2O
1mM Prp19(1-73); U-15N,13C 20mM phosphate buffer pH 7.0; 20mM NaCl
95% H2O/5% D2O
1mM Prp19(1-73); U-15N,13C 20mM phosphate buffer pH 7.0; 20mM NaCl
99% D2O
Guentert
structure solution
DYANA
1.5
Bruker
collection
XwinNMR
2.6
Bartels
data analysis
XEASY
1.3
Pearlman
refinement
Amber
6.0
800
Bruker
AVANCE
600
Bruker
AVANCE
500
Bruker
AVANCE
MET
1
n
1
MET
1
A
LEU
2
n
2
LEU
2
A
CYS
3
n
3
CYS
3
A
ALA
4
n
4
ALA
4
A
ILE
5
n
5
ILE
5
A
SER
6
n
6
SER
6
A
GLY
7
n
7
GLY
7
A
LYS
8
n
8
LYS
8
A
VAL
9
n
9
VAL
9
A
PRO
10
n
10
PRO
10
A
ARG
11
n
11
ARG
11
A
ARG
12
n
12
ARG
12
A
PRO
13
n
13
PRO
13
A
VAL
14
n
14
VAL
14
A
LEU
15
n
15
LEU
15
A
SER
16
n
16
SER
16
A
PRO
17
n
17
PRO
17
A
LYS
18
n
18
LYS
18
A
SER
19
n
19
SER
19
A
ARG
20
n
20
ARG
20
A
THR
21
n
21
THR
21
A
ILE
22
n
22
ILE
22
A
PHE
23
n
23
PHE
23
A
GLU
24
n
24
GLU
24
A
LYS
25
n
25
LYS
25
A
SER
26
n
26
SER
26
A
LEU
27
n
27
LEU
27
A
LEU
28
n
28
LEU
28
A
GLU
29
n
29
GLU
29
A
GLN
30
n
30
GLN
30
A
TYR
31
n
31
TYR
31
A
VAL
32
n
32
VAL
32
A
LYS
33
n
33
LYS
33
A
ASP
34
n
34
ASP
34
A
THR
35
n
35
THR
35
A
GLY
36
n
36
GLY
36
A
ASN
37
n
37
ASN
37
A
ASP
38
n
38
ASP
38
A
PRO
39
n
39
PRO
39
A
ILE
40
n
40
ILE
40
A
THR
41
n
41
THR
41
A
ASN
42
n
42
ASN
42
A
GLU
43
n
43
GLU
43
A
PRO
44
n
44
PRO
44
A
LEU
45
n
45
LEU
45
A
SER
46
n
46
SER
46
A
ILE
47
n
47
ILE
47
A
GLU
48
n
48
GLU
48
A
GLU
49
n
49
GLU
49
A
ILE
50
n
50
ILE
50
A
VAL
51
n
51
VAL
51
A
GLU
52
n
52
GLU
52
A
ILE
53
n
53
ILE
53
A
VAL
54
n
54
VAL
54
A
PRO
55
n
55
PRO
55
A
SER
56
n
56
SER
56
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
PHE
23
A
O
PHE
23
A
N
VAL
14
A
N
VAL
14
A
N
LEU
15
A
N
LEU
15
A
O
VAL
51
A
O
VAL
51
8
A
A
HG
OD2
SER
ASP
19
38
1.57
13
A
A
HG
OD2
SER
ASP
19
38
1.60
7
3.25
0.50
120.30
123.55
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
11
11
11
N
9
4.07
0.50
120.30
124.37
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
11
3.59
0.50
120.30
123.89
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
17
3.30
0.50
120.30
123.60
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
11
11
11
N
18
3.28
0.50
120.30
123.58
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
19
3.54
0.50
120.30
123.84
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
1
A
ARG
20
58.62
1.14
1
A
ASN
42
48.71
24.75
1
A
LEU
45
72.19
144.59
1
A
SER
46
-143.32
-61.50
2
A
ASN
42
47.42
25.17
2
A
LEU
45
71.79
133.92
2
A
SER
46
-135.12
-45.03
3
A
SER
6
-140.19
-6.62
3
A
PRO
10
-55.73
109.99
3
A
ARG
20
64.30
-3.94
3
A
LEU
45
70.10
147.70
3
A
SER
46
-146.38
-48.47
4
A
PRO
17
-56.33
-8.06
4
A
ARG
20
55.40
13.40
4
A
PRO
39
-56.76
-8.29
4
A
ASN
42
45.44
29.30
4
A
LEU
45
73.96
147.15
4
A
SER
46
-145.89
-57.79
5
A
ARG
20
59.86
11.25
5
A
ILE
40
-129.15
-50.16
5
A
LEU
45
69.25
139.87
5
A
SER
46
-139.01
-55.12
6
A
ARG
20
50.37
11.60
6
A
LEU
45
71.80
139.10
6
A
SER
46
-137.36
-51.58
7
A
ARG
20
55.61
4.50
7
A
LEU
45
66.33
128.27
7
A
VAL
54
-23.56
98.57
8
A
ARG
20
63.60
-1.53
8
A
LEU
45
65.10
149.14
8
A
SER
46
-142.86
-54.18
8
A
ILE
53
-96.60
57.72
9
A
ARG
20
56.23
7.97
9
A
LEU
45
72.00
132.69
9
A
SER
46
-132.95
-46.71
10
A
LEU
45
70.72
144.81
10
A
SER
46
-145.09
-52.40
11
A
ARG
20
47.92
17.66
11
A
ASN
42
49.68
21.33
11
A
LEU
45
70.86
141.43
11
A
SER
46
-140.99
-53.86
12
A
ILE
40
-124.80
-52.34
12
A
ASN
42
49.17
22.40
12
A
LEU
45
65.89
132.43
12
A
SER
46
-131.96
-48.00
13
A
PRO
17
-52.46
-7.68
13
A
ASN
42
51.70
19.78
13
A
LEU
45
66.00
143.16
13
A
SER
46
-136.15
-41.14
14
A
ARG
20
63.38
-2.00
14
A
ASN
42
48.44
23.50
14
A
LEU
45
73.72
137.71
14
A
SER
46
-138.69
-44.91
15
A
PRO
10
-54.85
105.16
15
A
ARG
20
58.32
-16.24
15
A
ASN
42
48.06
24.96
15
A
LEU
45
65.37
141.38
15
A
SER
46
-136.29
-54.54
16
A
ARG
20
59.94
1.72
16
A
LEU
45
65.44
132.30
16
A
SER
46
-129.63
-52.12
17
A
LYS
18
-82.20
-70.87
17
A
ARG
20
56.11
5.54
17
A
ASN
42
49.52
23.72
17
A
LEU
45
67.82
144.34
17
A
SER
46
-141.04
-49.52
18
A
LYS
18
-92.69
-67.85
18
A
ARG
20
59.25
5.67
18
A
ASN
42
45.10
23.86
18
A
LEU
45
70.45
146.29
18
A
SER
46
-143.70
-56.77
19
A
ASN
42
48.22
24.54
19
A
LEU
45
71.04
141.41
19
A
SER
46
-140.57
-45.84
20
A
ARG
20
57.47
10.88
20
A
LEU
45
73.86
144.14
20
A
SER
46
-147.50
-40.42
Solution structure of the U-box of Prp19
1
N
N
A
LYS
25
A
LYS
25
HELX_P
A
THR
35
A
THR
35
1
1
11
A
SER
46
A
SER
46
HELX_P
A
ILE
50
A
ILE
50
5
2
5
LIGASE/CELL CYCLE
Ubiquitin ligase, E3 ligase, U-box, LIGASE-CELL CYCLE COMPLEX
PRP19_YEAST
UNP
1
1
P32523
MLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKDTGNDPITNEPLSIEEIVEIVPS
1
56
1N87
1
56
P32523
A
1
1
56
3
anti-parallel
anti-parallel
A
PHE
23
A
PHE
23
A
GLU
24
A
GLU
24
A
PRO
13
A
PRO
13
A
LEU
15
A
LEU
15
A
VAL
51
A
VAL
51
A
GLU
52
A
GLU
52
1
P 1